Coverage
-
July 03, 2012
Kidney care provider DaVita Inc. said Monday it had reached a $55 million settlement agreement in a qui tam False Claims Act suit alleging it fraudulently billed the federal government for free supplies of Amgen Inc.'s anemia drug Epogen.
1 other articles on this case.
View all »